000 | 01591 a2200409 4500 | ||
---|---|---|---|
005 | 20250515064920.0 | ||
264 | 0 | _c20070517 | |
008 | 200705s 0 0 eng d | ||
022 | _a1744-7658 | ||
024 | 7 |
_a10.1517/13543784.16.5.569 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKonstantinopoulos, Panagiotis A | |
245 | 0 | 0 |
_aFocus on acetylation: the role of histone deacetylase inhibitors in cancer therapy and beyond. _h[electronic resource] |
260 |
_bExpert opinion on investigational drugs _cMay 2007 |
||
300 |
_a569-71 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAcetylation _xdrug effects |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aCell Differentiation _xdrug effects |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aEpigenesis, Genetic _xdrug effects |
650 | 0 | 4 |
_aHistone Acetyltransferases _xmetabolism |
650 | 0 | 4 | _aHistone Deacetylase Inhibitors |
650 | 0 | 4 |
_aHistone Deacetylases _xmetabolism |
650 | 0 | 4 |
_aHistones _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 |
_aNeurodegenerative Diseases _xdrug therapy |
700 | 1 | _aKaramouzis, Michalis V | |
700 | 1 | _aPapavassiliou, Athanasios G | |
773 | 0 |
_tExpert opinion on investigational drugs _gvol. 16 _gno. 5 _gp. 569-71 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1517/13543784.16.5.569 _zAvailable from publisher's website |
999 |
_c17010801 _d17010801 |